CD276 and cancer: For the DSS and PFI rates, we used univariate Cox regression analysis to show that a high expression level of CD276 correlated with low survival in the majority of cancer types, including BRCA, ACC, COAD, LGG, MESO and UVM, whereas a high expression level of CD276 appears to be a protective element for DLBC.